Lundbeck
HLUN-B.CO
#2558
Rank
C$7.76 B
Marketcap
$8.15
Share price
0.05%
Change (1 day)
25.35%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): $0.48

According to Lundbeck 's latest financial reports the company's current EPS (TTM) is $0.51. In 2022 the company made an earnings per share (EPS) of $0.39 a decrease over its 2021 EPS that were of $0.88.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$0.4822.42%
2022$0.39-55.47%
2021$0.88-51.83%
2020$1.82-28.01%
2019$2.53-44.08%
2018$4.5251.94%
2017$2.97126.64%
2016$1.31-120.84%
2015-$6.295622.18%
2014-$0.11-110.03%
2013$1.10-28.08%
2012$1.52-52.1%
2011$3.18-1.31%
2010$3.2215.61%
2009$2.79